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Background
Co-stimulatory molecules play a critical role in the devel-
opment of cellular immunity. Understanding how co-
stimulatory pathways interact and influence the immune
response is critical for the generation of an effective HIV
vaccine. We evaluated the ability of intravenous adminis-
tration of blocking monoclonal antibodies (mAb)
directed against the negative co-stimulatory molecule,
CTLA-4, and an agonist mAb directed against the positive
co-stimulatory molecule, 41BB, to augment intramuscular
SIV DNA immunizations. We then tested the ability of
these responses to impact a SIVmac251 challenge.
Methods
Groups of six cynomologous macaques were immunized
intramuscularly five times with consensus SIV gag, env,
and pol plasmid DNA. On the day of each immunization,
as well as two days later, macaques were infused with 10
mg/kg of an anti-41BB mAb, an anti-CTLA-4 mAb, both,
or without antibodies. Cellular immune responses were
evaluated by ELISpot, CFSE proliferation, and ICS for
polyfunctionality. Three months following the final
immunization, the animals were intra-rectally challenged
with a high-dose of SIVmac251.
Results
Following immunization, the groups infused with the
anti-41BB mAb had enhanced IFNγ responses compared
to the DNA group (average 7,500 and 5,000 SFU/106
PBMCs, respectively). Although CTLA-4 blockade alone
did not enhance IFNγ responses it did increase T cell pro-
liferation. The combination of mAbs enhanced the mag-
nitude of the polyfunctional CD8+ T-cell response.
Following challenge, the group that received both mAbs
had a significant, 2 log, decrease in plasma viral load com-
pared to the naïve group (4.16 × 105 and 5.13 × 107 viral
copies/ml of plasma, respectively, p = 0.0266, Kruskal-
Wallis).
Conclusion
These data demonstrate the utility of targeting co-stimula-
tory pathways to modulate cellular immunity following
DNA vaccination. CTLA-4 blockade and 41BB stimulation
during immunization resulted in a significant decrease in
peak viral load following SIVmac251 challenge. Our
results represent a considerable improvement in the effi-
cacy of naked intramuscular DNA vaccines in macaques.
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